EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Intravenous topiramate for seizure emergencies – First in human case report

Loukia Apostolakopoulou, Pilar Bosque Varela, Fabio Rossini, Ciara O'Sullivan, Wolfgang Löscher, Giorgi Kuchukhidze, Eugen Trinka

Epilepsy & Behavior · 2023

DOI: 10.1016/j.yebeh.2023.109158 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Epilepsy & Behavior, 2023. Verfasst von Loukia Apostolakopoulou und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Greece; Department of Neurolog…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topiramate (TPM) is widely used in focal and generalized epilepsies. It is commercially available as tablets and sprinkles capsules for oral treatment. Previous studies comparing intravenous (IV) to oral TPM in healthy adults showed more rapid pharmacodynamic effects in cases of IV administration. Despite promising findings, no clinical application in humans followed. We present a case of a pregnant woman with idiopathic generalized epilepsy who experienced a generalized tonic-clonic seizure in the third trimenon due to low TPM levels attributed to pregnancy followed by repeated prolonged absences. We applied a new meglumine-based solution (1%) of TPM (10 mg/ml) in two IV infusions of 200 mg each under EEG monitoring over a total duration of 1 hour. The infusion was well tolerated and led to a rapid increase in plasma TPM levels. A clinical as well as electroencephalographic improvement was documented within the first hours. To the best available knowledge, this is the first reported case where IV TPM was used therapeutically for seizure treatment in humans. It is also the first time that the new meglumine-based solution was used in a human with epilepsy. The advantages of IV route delivery and the solution's quick preparation, high tolerability, and low toxicity make it ideal for use in many clinical settings and high-care patients. IV TPM seems to be a reasonable adjunctive option for adults with seizures, previously stabilized on oral TPM, who need rapid plasma concentration boosting. Although our experience was successful in using injectable TPM in seizure emergencies, randomized controlled clinical trials are required to make recommendations for the use of IV TPM on patients with epilepsy. This paper was presented at the 8th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures held in September 2022 in Salzburg, Austria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyAdultFemaleHumansTopiramateEmergenciesFructoseTreatment OutcomeSeizures

Stichwörter der Autor:innen

Antiseizure medicationEpilepsyIntravenousNew drugPregnancyTopiramate

Substanzen

TopiramateAnticonvulsantsFructose

Autor:innen und Institutionen

  • First Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Greece; Department of Neurology, Christian Doppler University Hospital, Member of the European Refer…
  • Department of Neurology, Christian Doppler University Hospital, Member of the European Reference Network EpiCARE, and Centre for Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria; Neuroscience Ins…
  • Department of Neurology, Christian Doppler University Hospital, Member of the European Reference Network EpiCARE, and Centre for Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria.
  • Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine, Hannover, Germany; Center for Systems Neuroscience, Hannover, Germany.

Zitieren

APA

Apostolakopoulou, L., Bosque Varela, P., Rossini, F., O'Sullivan, C., Löscher, W., Kuchukhidze, G., & Trinka, E. (2023). Intravenous topiramate for seizure emergencies – First in human case report. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109158

Vancouver

Apostolakopoulou L, Bosque Varela P, Rossini F, O'Sullivan C, Löscher W, Kuchukhidze G, et al. Intravenous topiramate for seizure emergencies – First in human case report. Epilepsy & Behavior. 2023. doi:10.1016/j.yebeh.2023.109158

BibTeX
@article{Apostolakopoulou2023,
  author = {Apostolakopoulou, Loukia and Bosque Varela, Pilar and Rossini, Fabio and O'Sullivan, Ciara and Löscher, Wolfgang and Kuchukhidze, Giorgi and Trinka, Eugen},
  title = {Intravenous topiramate for seizure emergencies – First in human case report},
  journal = {Epilepsy & Behavior},
  year = {2023},
  doi = {10.1016/j.yebeh.2023.109158}
}
Kostenlos starten →